Effects Of Antidepressants On Sexual Functioning In Adults
NCT00051272 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 425
Last updated 2011-03-29
Summary
This study will evaluate the effects of two antidepression medications on sexual functioning.
Conditions
- Major Depressive Disorder (MDD)
Interventions
- DRUG
-
Extended-release Bupropion Hydrochloride
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials, MD · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Primary Completion
- 2004-06-30
- Completion
- 2004-06-30
Countries
- United States
Study Locations
More Related Trials
-
Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder
NCT00135421 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women
NCT05685407 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder
NCT00432614 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
NCT01741142 ·Status: TERMINATED ·Phase: PHASE2
-
Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder
NCT01541475 ·Status: COMPLETED ·Phase: PHASE4
-
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
NCT04352101 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD
NCT00785434 ·Status: COMPLETED ·Phase: PHASE4
-
Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression
NCT00429169 ·Status: TERMINATED ·Phase: PHASE4
-
SSRI and Buprenorphine
NCT00475878 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test Different Doses of BI 1569912 in People With Depression
NCT06558344 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With Depression
NCT00106197 ·Status: UNKNOWN ·Phase: PHASE4
-
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT05061706 ·Status: COMPLETED ·Phase: PHASE3
-
Escitalopram in Adult Patients With Major Depressive Disorder
NCT00668525 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder
NCT02741791 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication
NCT04937829 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD)
NCT05081167 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Depression in Adults
NCT00073697 ·Status: COMPLETED ·Phase: PHASE4
-
BPL-003 Efficacy and Safety in Treatment Resistant Depression
NCT05870540 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
NCT01111552 ·Status: TERMINATED ·Phase: PHASE3
-
Memory Functioning and Antidepressant Treatment
NCT00296933 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
NCT00252356 ·Status: COMPLETED ·Phase: PHASE3
-
Augmenting Antidepressant Treatment With Interpersonal Psychotherapy for Treating Late-life Depression
NCT00177294 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
NCT00109044 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression
NCT01814085 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD
NCT03131050 ·Status: COMPLETED ·Phase: PHASE4